104 related articles for article (PubMed ID: 6259604)
1. [Treatment of Gram-negative septicaemia with cefotaxime: 16 cases (author's transl)].
Goulon M; Gajdos P; Pilliot J
Nouv Presse Med; 1981 Feb; 10(8):613-6. PubMed ID: 6259604
[TBL] [Abstract][Full Text] [Related]
2. [Cefotaxime in septicaemia and severe infections due to multiresistant Gram-negative bacilli (author's transl)].
Dureux JB; Canton P; Roche G; Weber M; Gérard A
Nouv Presse Med; 1981 Feb; 10(8):601-6. PubMed ID: 6259602
[TBL] [Abstract][Full Text] [Related]
3. [Cefotaxime and Gram-negative infections in children. Effectiveness and tolerance (author's transl)].
Aufrant C; Lambert-Zechovsky N; Aujard Y; Bingen E; Blum C; Beaufils F; Mathieu H
Nouv Presse Med; 1981 Feb; 10(8):639-46. PubMed ID: 6259610
[TBL] [Abstract][Full Text] [Related]
4. [Clinical experience of cefotaxime (author's transl)].
Portier H; Carbon C; Boussougant Y; Destaing F
Nouv Presse Med; 1981 Feb; 10(8):607-11. PubMed ID: 6259603
[TBL] [Abstract][Full Text] [Related]
5. [The use of cefotaxime against infections (author's transl)].
Lepeu G; Bertrand A; Armengaud M; Aubertin J
Nouv Presse Med; 1981 Feb; 10(8):594-7. PubMed ID: 6259600
[TBL] [Abstract][Full Text] [Related]
6. [Place of cefotaxime in the treatment of septicaemias due to enterobacteriaceae (author's transl)].
Bastin R; Frottier J; Vilde JL; Bure A
Nouv Presse Med; 1981 Feb; 10(8):598-600. PubMed ID: 6259601
[TBL] [Abstract][Full Text] [Related]
7. [Clinical evaluation of cefotaxime at various dosage levels in urinary tract infections (author's transl)].
Guibert J; Acar JF; Justin C; Kitzis MD
Nouv Presse Med; 1981 Feb; 10(8):625-7. PubMed ID: 6259607
[TBL] [Abstract][Full Text] [Related]
8. [Cefotaxime in the treatment of severe infections due to multiresistant Gram-negative bacilli (author's transl)].
Clumeck N; Van Laethem Y; Vanhoof R; Jaspar N; George G; Rapin M; Butzler JP
Nouv Presse Med; 1981 Feb; 10(8):622-4. PubMed ID: 6259606
[TBL] [Abstract][Full Text] [Related]
9. [Combined cefotaxime-amikacin treatment of infectious episodes in acute leukaemia patients with therapeutically-induced bone marrow aplasia (author's transl)].
Guy H; Chavanet P; Portier H; Kazmierczak A; Cortet P
Nouv Presse Med; 1981 Feb; 10(8):654-6. PubMed ID: 6259613
[TBL] [Abstract][Full Text] [Related]
10. [Cefotaxime in digestive tract infections (author's transl)].
Paris J; Paris JC; Gérard A
Nouv Presse Med; 1981 Feb; 10(8):647-9. PubMed ID: 6259611
[TBL] [Abstract][Full Text] [Related]
11. [Cefotaxime treatment of 25 cases of severe enterobacteriaceae infections in an intensive care unit (author's transl)].
Motin J; Bouletreau P; Auboyer C; Bui-Xuan B; Flandrois JP; Reverdy ME
Nouv Presse Med; 1981 Feb; 10(8):617-21. PubMed ID: 6259605
[No Abstract] [Full Text] [Related]
12. [Cefotaxime in bronchopulmonary infections (author's transl)].
Kermarec J; Sauvaget J
Nouv Presse Med; 1981 Feb; 10(8):650-3. PubMed ID: 6259612
[TBL] [Abstract][Full Text] [Related]
13. [Cefotaxime in the treatment of purulent meningitis in children (author's transl)].
Borderon JC; Despert F; Santini JJ; Laugier J; Grenier B; Boulard P
Nouv Presse Med; 1981 Feb; 10(8):634-8. PubMed ID: 6259609
[TBL] [Abstract][Full Text] [Related]
14. Comparison of clinical cure rates in adults with ventilator-associated pneumonia treated with intravenous ceftazidime administered by continuous or intermittent infusion: a retrospective, nonrandomized, open-label, historical chart review.
Lorente L; Jiménez A; Palmero S; Jiménez JJ; Iribarren JL; Santana M; Martín MM; Mora ML
Clin Ther; 2007 Nov; 29(11):2433-9. PubMed ID: 18158083
[TBL] [Abstract][Full Text] [Related]
15. [Cefotaxime in childhood infections (author's transl)].
Garnier JM; Giraud F
Nouv Presse Med; 1981 Feb; 10(8):629-33. PubMed ID: 6259608
[TBL] [Abstract][Full Text] [Related]
16. [Use of cefotaxime in severe infections in newborn infants].
Peskine F; Astruc J; Rodiére M; Echenne B; Brunel D
Pathol Biol (Paris); 1984 Dec; 32(10):1040-2. PubMed ID: 6096793
[TBL] [Abstract][Full Text] [Related]
17. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Deal EN; Micek ST; Reichley RM; Ritchie DJ
Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
[TBL] [Abstract][Full Text] [Related]
18. [Cefotaxime CSF levels in children with purulent meningitis (author's transl)].
Borderon JC; Prieur D; Huguet B
Nouv Presse Med; 1981 Feb; 10(8):580-4. PubMed ID: 6259596
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the clinical significance of production of extended-spectrum beta-lactamases (ESBL) by Enterobacteriaceae.
Henshke-Bar-Meir R; Yinnon AM; Rudensky B; Attias D; Schlesinger Y; Raveh D
Infection; 2006 Apr; 34(2):66-74. PubMed ID: 16703295
[TBL] [Abstract][Full Text] [Related]
20. Cefotaxime monotherapy in septicemic patients with hematological malignancies.
Plesner AM; Hansen MM; Nissen NI; Friis H
Clin Ther; 1986; 9(1):97-105. PubMed ID: 3815462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
